Business
Posting of Annual Report & Accounts &Notice of AGM
Posting of Annual Report & Accounts &Notice of AGM.
About this update from Cambridge Nutritional Sciences Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 1008H\n Omega Diagnostics Group PLC\n 30 July 2021\n \n \n \n \n OMEGA DIAGNOSTICS GROUP PLC \n \n \n (\"Omega\" or the \"Company\" or the \"Group\")\n \n \n \n \n \n Posting of Annual Report and Accounts and Notice of AGM\n \n \n \n \n \n Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, announces that the Notice of Annual General Meeting ('AGM') along with the Annual Report and Accounts for the year ended 31 March 2021 have today been posted to shareholders and are available from the Company's website at: \n \n \n \n \n \n \n \n https://www.omegadiagnostics.com/Investor-Relations/Corporate-Information/Annual-Report-and-Interim-Results\n \n \n \n \n \n \n \n \n The AGM of the Company will be held on Wednesday 15 September at 11am at \n Omega House, Hillfoots Business Village, Alva, Clackmannanshire, FK12 5DQ.\n \n \n \n \n \n \n \n \n Contacts: \n \n \n \n \n \n \n \n \n Omega Diagnostics Group PLC \n \n \n \n \n \n \n www.omegadiagnostics.com\n \n \n \n \n \n \n \n \n Colin King, Chief Executive \n \n \n \n \n via Walbrook PR\n \n \n \n \n \n \n Kieron Harbinson, Group Finance Director\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n finnCap Ltd\n \n \n \n \n \n \n Tel: 020 7220 0500\n \n \n \n \n \n \n Geoff Nash/Edward Whiley (Corporate Finance)\n \n \n \n \n \n \n \n \n \n \n \n \n \n Alice Lane (ECM)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Walbrook PR Limited\n \n \n \n \n Tel: 020 7933 8780 or \n \n \n [email protected]\n \n \n \n \n \n \n \n \n Paul McManus\n \n \n \n \n Mob: 07980 541 893\n \n \n \n \n \n \n Lianne Cawthorne\n \n \n \n \n Mob: 07584 391 303\n \n \n \n \n \n \n \n \n \n This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage ...